Insider Transactions in Q1 2026 at Halozyme Therapeutics, Inc. (HALO)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 05
2026
|
Bernadette Connaughton Director |
SELL
Open market or private sale
|
Direct |
2,000
-4.75%
|
$140,000
$70.25 P/Share
|
|
Jan 03
2026
|
Mark Howard Snyder SVP, CHIEF LEGAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,243
-11.04%
|
$297,010
$70.31 P/Share
|
|
Jan 03
2026
|
Mark Howard Snyder SVP, CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,611
+16.53%
|
-
|
|
Jan 02
2026
|
James Paul Lang Director |
BUY
Grant, award, or other acquisition
|
Direct |
889
+50.0%
|
-
|